Performance of 2019 ESC risk classification and the Steno type 1 risk engine in predicting cardiovascular events in adults with type 1 diabetes: A retrospective study

被引:4
|
作者
Tecce, Nicola [1 ]
Masulli, Maria [1 ]
Palmisano, Luisa [1 ]
Gianfrancesco, Salvatore [1 ]
Piccolo, Roberto [1 ]
Pacella, Daniela [2 ]
Bozzetto, Lutgarda [1 ]
Massimino, Elena [1 ]
Della Pepa, Giuseppe [1 ]
Lupoli, Roberta [3 ]
Vaccaro, Olga [1 ]
Riccardi, Gabriele [1 ]
Capaldo, Brunella [1 ]
机构
[1] Univ Naples Federico II, Dept Clin Med & Surg, Via S Pansini 5, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy
[3] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy
关键词
Type; 1; diabetes; Cardiovascular disease; STENO Type 1 risk engine; 2019 ESC guidelines; DISEASE; MORTALITY; 1ST;
D O I
10.1016/j.diabres.2022.110001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: The study compares the performance of the European Society of Cardiology (ESC) risk criteria and the Steno Type 1 Risk Engine (ST1RE) in the prediction of cardiovascular (CV) events. Methods: 456 adults with type 1 diabetes (T1D) were retrospectively studied. During 8.5 +/- 5.5 years of observation, twenty-four patients (5.2%) experienced a CV event. The predictive performance of the two risk models was evaluated by classical metrics and the event-free survival analysis. Results: The ESC criteria show excellent sensitivity (91.7%) and suboptimal specificity (64.4 %) in predicting CV events in the very high CV risk group, but a poor performance in the high/moderate risk groups. The ST1RE algorithm shows a good predictive performance in all CV risk categories. Using ESC classification, the event-free survival analysis shows a significantly higher event rate in the very high CV risk group compared to the high/moderate risk group (p < 0.0019). Using the ST1RE algorithm, a significant difference in the event-free survival curve was found between the three CV risk categories (p < 0.0001). Conclusions: In T1D the ESC classification has a good performance in predicting CV events only in those at very high CV risk, whereas the ST1RE algorithm has a good performance in all risk categories.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Assessing cardiovascular risk in Type 1 diabetes
    Schofield, J. D.
    Liu, Y.
    Siahmansur, T.
    Pemberton, P.
    Hobkirk, J.
    Stevens, A.
    Whitelaw, D.
    Carroll, S.
    Malik, R.
    Soran, H.
    DIABETIC MEDICINE, 2017, 34 : 51 - 51
  • [22] Cardiovascular risk factors in type 1 diabetes
    Syed, Ateeq A.
    Gangopadhyay, Kalyan
    Narendran, Parth
    DIABETES, 2007, 56 : A585 - A585
  • [23] Elevated triglyceride-glucose index is a risk factor for cardiovascular events in adults with type 1 diabetes: a cohort study
    Oh, Rosa
    Kim, Seohyun
    Park, Sang Ho
    Jang, Myunghwa
    Cho, So Hyun
    Kim, Ji Yoon
    Lee, You-Bin
    Jin, Sang-Man
    Hur, Kyu Yeon
    Kim, Gyuri
    Kim, Jae Hyeon
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
  • [24] Cardiovascular Risk in Type 1 Diabetes Mellitus
    Jonathan Schofield
    Jan Ho
    Handrean Soran
    Diabetes Therapy, 2019, 10 : 773 - 789
  • [25] Cardiovascular disease risk in type 1 diabetes
    Anagnostis, Panagiotis
    Godsland, Ian F.
    Lancet Diabetes & Endocrinology, 2015, 3 (05): : 316 - 317
  • [26] Type 1 diabetes mellitus and cardiovascular risk
    Jose Chillaron, Juan
    Francisco Cano, Juan
    Pedro-Botet, Juan
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2008, 20 (05): : 210 - 217
  • [27] Cardiovascular Risk Management in Type 1 Diabetes
    I. H. Teoh
    P. Elisaus
    J. D. Schofield
    Current Diabetes Reports, 2021, 21
  • [28] Cardiovascular Risk Management in Type 1 Diabetes
    Teoh, I. H.
    Elisaus, P.
    Schofield, J. D.
    CURRENT DIABETES REPORTS, 2021, 21 (09)
  • [30] Clinical profiles and quality of care of adults with type 1 diabetes according to their cardiovascular Risk: A Multicenter, Observational, retrospective study
    Pintaudi, Basilio
    Scatena, Alessia
    Piscitelli, Gabriella
    Frison, Vera
    Corrao, Salvatore
    Manicardi, Valeria
    Graziano, Giusi
    Rossi, Maria Chiara
    Gallo, Marco
    Mannino, Domenico
    Nicolucci, Antonio
    Di Bartolo, Paolo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 182